Resources

Explore our latest research articles and industry analyses to stay ahead in the rapidly evolving biopharmaceutical landscape. From breakthrough therapies to regulatory developments, we deliver authoritative content to support your professional growth in this dynamic field.

Industry Insight: Rapid Success of EsoBiotec’s FIH IIT Program & $1B Acquisition by AstraZeneca

A landmark cell therapy industry milestone took place in early 2025: EsoBiotec kicked off its ESO-T01 First-in-Human investigator-initiated trial (FIH IIT) in Wuhan on January 8, 2025.
2025/01/30